When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Novartis is now a pure player in innovative medicines.
Despite a negative FX, the company reported solid 2023 financial results and increased its dividend per share.
There is a strategic rationale for acquiring MorphoSys AG. NVS had raised its outlook for three quarters in a row. We have now moved our rating to buy.
Following the Sandoz spin-off and Alcon sale, Novartis ( NVS ) (NVSEF) has completed a big step in its transformation into a pure-play in innovative medicines ( Fig 1 )....